Suppr超能文献

在六个欧洲国家的育龄女性中识别多发性硬化症:ConcePTION项目的一项贡献。

Identifying multiple sclerosis in women of childbearing age in six European countries: a contribution from the ConcePTION project.

作者信息

Beslay Marie, Geissbühler Yvonne, Beau Anna-Belle, Messina Davide, Benevent Justine, Ballardini Elisa, Barrachina-Bonet Laia, Cavero-Carbonell Clara, Coldea Alex, García-Villodre Laura, Geldhof Anja, Gini Rosa, Hellwig Kerstin, Jordan Sue, Leinonen Maarit K, Lopez-Leon Sandra, Manfrini Marco, Martikainen Visa, Mitter Vera R, Neville Amanda J, Nordeng Hedvig, Puccini Aurora, Vukusic Sandra, Morris Joan K, Damase-Michel Christine

机构信息

CERPOP-SPHERE Team, Toulouse University Hospital, Inserm UMR 1295, Toulouse University, Toulouse, France.

Evidence Generation, Novartis Pharma AG, Basel, Switzerland.

出版信息

Eur J Epidemiol. 2025 Jul 18. doi: 10.1007/s10654-025-01264-3.

Abstract

Prevalence of Multiple Sclerosis (MS) has increased over the last decades, primarily among women of childbearing age. Several algorithms for identifying MS have been described in the literature, providing heterogeneous prevalence estimates. We compared five algorithms to identify MS in women of childbearing age and estimated MS prevalence by time period and age-group. The study population included women aged 15 to 49 years-old between 2005 and 2019, from three data sources including all women (from Italy, Norway, and Wales), and three including pregnant women only (from France, Finland, and Spain; data collected around pregnancy). Five algorithms were tested: MS1 to MS3 combined MS diagnoses and MS-medicine prescriptions/dispensations, requiring 1, 2, or 3 occurrences, respectively; MS4 and MS5 used only MS diagnoses, requiring at least 2 occurrences (MS4 allowed just 1 if diagnosis was from inpatient care). In 2015-2019, MS prevalence based on MS1 ranged from 109 to 359 per 100,000 women: 109 in France, 121 in Spain, 195 in Wales, 232 in Finland, 264 in Italy, and 359 in Norway. More restrictive algorithms led to greater disparity, with MS3 ranging from 53 in Spain to 325 in Norway, and MS5 from 21 in France to 345 in Norway. All algorithms showed expected prevalence trends by time and age among women of childbearing age, though lower than in the literature. Overall, MS1 provided prevalence estimates most closely aligned with existing literature. This study offers key insights into choosing algorithms for identifying MS in women of childbearing age and in pregnant women.

摘要

在过去几十年中,多发性硬化症(MS)的患病率有所上升,主要是在育龄妇女中。文献中描述了几种用于识别MS的算法,这些算法提供的患病率估计存在差异。我们比较了五种算法以识别育龄妇女中的MS,并按时间段和年龄组估计MS患病率。研究人群包括2005年至2019年期间年龄在15至49岁之间的女性,来自三个数据源,包括所有女性(来自意大利、挪威和威尔士),以及三个仅包括孕妇的数据源(来自法国、芬兰和西班牙;在孕期收集的数据)。测试了五种算法:MS1至MS3结合了MS诊断和MS药物处方/配药,分别需要1次、2次或3次出现;MS4和MS5仅使用MS诊断,需要至少2次出现(如果诊断来自住院治疗,MS4允许仅1次)。在2015 - 2019年期间,基于MS1的MS患病率为每10万名女性109至359例:法国为109例,西班牙为121例,威尔士为195例,芬兰为232例,意大利为264例,挪威为359例。更严格的算法导致差异更大,MS3从西班牙的53例到挪威的325例,MS5从法国的21例到挪威的345例。所有算法在育龄妇女中按时间和年龄均显示出预期的患病率趋势,尽管低于文献中的数据。总体而言,MS1提供的患病率估计与现有文献最为接近。这项研究为选择用于识别育龄妇女和孕妇中MS的算法提供了关键见解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验